Cystic Fibrosis Market Size, Share, Growth, Outlook, and Opportunity Analysis, Forecast 2018 - 2026
Cystic Fibrosis Market |
Cystic fibrosis is a hereditary disease that mostly affects the lungs, but also affects the pancreas, liver, and kidney. The cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation causes it. This gene, which is found on chromosome 7, is in charge of perspiration, mucus, and bodily fluids regulation. However, a mutation in this gene causes CFTR activity to be absent, resulting in chloride loss and protein structural changes. Patients have difficulties breathing, mucus development, greasy stool, and obstructions in the pancreatic, bile duct, gut, and salivary gland passageways.
The market is being triggered by a growing number of people suffering from CF all over the world. The developments in CF pharmacotherapy have resulted in a number of advancements in the treatment of this ailment, which is favourably boosting market growth. Furthermore, market trends in disease treatment are driving Cystic Fibrosis Market expansion, thanks to an increasing number of pipeline candidates from large firms aiming for therapeutic care. As a result, manufacturers are introducing enhanced treatment that targets CFTR protein anomalies. In addition, the introduction of Ivacaftor / Lumacaftor, a potentiator that enhances the lives of people living with the condition, is boosting market growth.
According to Netwellness, a community service provider, 3 to 4% of children are born with genetic abnormalities. This number is likely to rise in the next years, particularly in Asia's growing economies, such as China and India, due to the high birth rate in these areas. The need for cystic fibrosis therapy will rise as the number of cystic fibrosis cases rises, driving the total cystic fibrosis market's growth over the forecast period.
Market Segmentation:
By Route Of Administration
By Drug Class
By Route Of Administration
- Oral
- Inhaled
By Drug Class
- Pancreatic Enzyme Supplements
- Mucolytic
- Bronchodilators
- CFTR modulators
Some of the key players operating in the global cystic fibrosis market are AbbVie, Inc., Aradigm, Aurora Biosciences, Bayer AG, Demegen, EryDel, Genentech, Inc., InDex Pharmaceuticals, ManRos Therapeutics, Novartis AG, Polydex Pharmaceuticals, and F. Hoffmann-La Roche AG.
Source Link: https://tamildada.info/cystic-fibrosis-a-growing-concern-over-this-hereditary-condition-which-mostly-affects-the-digestive-system/
Comments
Post a Comment